DDIT3 and diffuse large B-cell lymphoma: To validate this observation in human DLBCL patients, we quantified the VEGF-A levels in the urine of patients receiving Ro+R-CHOP and compared it to the values found in a contemporary local cohort of DLBCL patients treated with SOC R-CHOP.